Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis [7]

Clinical and Experimental Rheumatology

Volumn 23, Issue 6, 2005, Pages 916-917

  Marchesoni, Antonio ^a   Sarzi Puttini, P ^b   Gorla, R ^c   Caporali, R ^d   Arnoldi, C ^a   Atzeni, F ^b   Vianelli, M ^c   Bobbio Pallavicini, F ^d  

^a G Pini Orthopaedic Institute   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Rheumatology and Clinical Immunology   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; HYPERTENSION; HYPERTRICHOSIS; ITALY; LETTER; MALE; NAUSEA; NEPHROTOXICITY; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; RANK SUM TEST; RELAPSE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SCROTUM DISORDER; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED;

EID: 29944441914     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. GREMESE E, FERRACCIOLI GF: Benefit/risk of cyclosporine in rheumatoid arthritis. Clin Exp Rheumatol 2004; 22 (Suppl. 35): S101-7.
2. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
3. Van de HEIJDE DMFM, van't HOF MA, Van RIEL PLCM, Van de PUTTE LBA: Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993; 20: 579-81.
4. Van GESTEL AM, PREVOO ML, vant't HOF MA, van RIJSWIJCK MH, van de PUTTE LB, van RIEL PL: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996; 39: 34-40.
5. SIDIROPOULOS P, SIAKKA P, CHOULAKI C et al.: Addition of cyclosporine-A in rheumatoid arthritis patients on anti-TNF and methotrexate therapy: an open-label, pilot study. Ann Rheum Dis 2004; 63 (Suppl. 1): FRI189 (abstract).